Notice of Interim Results

15 Aug 2016

Shield Therapeutics plc (LSE:STX), a specialty pharmaceutical company focused on secondary care, announces it will report its interim results for the six months ended 30 June 2016 on Tuesday 20 September 2016.

Carl Sterritt, Chief Executive Officer, Richard Jones, Chief Financial Officer, and Paul Steckler, VP Commercial Operations, will host a presentation and live conference call for analysts at 11.00am BST on the morning of results in the Guildhall Room at 85 Gresham Street, London, EC2V 7NQ.

Back to news